JP2022530742A5 - - Google Patents

Info

Publication number
JP2022530742A5
JP2022530742A5 JP2021558521A JP2021558521A JP2022530742A5 JP 2022530742 A5 JP2022530742 A5 JP 2022530742A5 JP 2021558521 A JP2021558521 A JP 2021558521A JP 2021558521 A JP2021558521 A JP 2021558521A JP 2022530742 A5 JP2022530742 A5 JP 2022530742A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
chimeric protein
protein complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021558521A
Other languages
English (en)
Japanese (ja)
Other versions
JP7773371B2 (ja
JP2022530742A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/025423 external-priority patent/WO2020198662A1/en
Publication of JP2022530742A publication Critical patent/JP2022530742A/ja
Publication of JP2022530742A5 publication Critical patent/JP2022530742A5/ja
Priority to JP2025076699A priority Critical patent/JP2025118769A/ja
Application granted granted Critical
Publication of JP7773371B2 publication Critical patent/JP7773371B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021558521A 2019-03-28 2020-03-27 Clec9aベースキメラタンパク質複合体 Active JP7773371B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076699A JP2025118769A (ja) 2019-03-28 2025-05-02 Clec9aベースキメラタンパク質複合体

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962825584P 2019-03-28 2019-03-28
US62/825,584 2019-03-28
US201962906442P 2019-09-26 2019-09-26
US62/906,442 2019-09-26
PCT/US2020/025423 WO2020198662A1 (en) 2019-03-28 2020-03-27 Clec9a-based chimeric protein complexes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076699A Division JP2025118769A (ja) 2019-03-28 2025-05-02 Clec9aベースキメラタンパク質複合体

Publications (3)

Publication Number Publication Date
JP2022530742A JP2022530742A (ja) 2022-07-01
JP2022530742A5 true JP2022530742A5 (https=) 2023-03-31
JP7773371B2 JP7773371B2 (ja) 2025-11-19

Family

ID=72609002

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021558521A Active JP7773371B2 (ja) 2019-03-28 2020-03-27 Clec9aベースキメラタンパク質複合体
JP2025076699A Pending JP2025118769A (ja) 2019-03-28 2025-05-02 Clec9aベースキメラタンパク質複合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076699A Pending JP2025118769A (ja) 2019-03-28 2025-05-02 Clec9aベースキメラタンパク質複合体

Country Status (8)

Country Link
US (2) US12351614B2 (https=)
EP (1) EP3947429A4 (https=)
JP (2) JP7773371B2 (https=)
KR (1) KR20220012227A (https=)
CN (2) CN113840833B (https=)
AU (1) AU2020244880A1 (https=)
CA (1) CA3133831A1 (https=)
WO (1) WO2020198662A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7773372B2 (ja) 2019-03-28 2025-11-19 オリオニス バイオサイエンシズ,インコーポレイテッド 線維芽細胞活性化タンパク質結合物質およびその使用
US12351614B2 (en) * 2019-03-28 2025-07-08 Orionis Biosciences, Inc. CLEC9A-based chimeric protein complexes
CN116547003A (zh) * 2020-10-05 2023-08-04 莫纳什大学 Clec9a抗体
EP4724475A2 (en) * 2023-06-09 2026-04-15 Orionis Biosciences, Inc. Clec9a-based chimeric protein formulations

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69007975T2 (de) 1989-08-22 1994-07-21 Immunex Corp Fusionsprotein bestehend aus gm-csf und il-3.
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US5914254A (en) 1993-08-02 1999-06-22 Celtrix Pharmaceuticals, Inc. Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
AU2003281200A1 (en) 2002-07-03 2004-01-23 Tasuku Honjo Immunopotentiating compositions
US20110020273A1 (en) 2005-04-06 2011-01-27 Ibc Pharmaceuticals, Inc. Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
EP1812038A1 (en) 2004-11-18 2007-08-01 VIB vzw Fibronectin iii domain as leptin receptor antagonists
WO2006115800A2 (en) 2005-04-15 2006-11-02 The Regents Of The University Of California Enhanced wound healing utilizing an anti-her2 antibody coupled to a tnf alpha
US7947265B2 (en) 2006-08-02 2011-05-24 Mcgill University Fusion proteins and methods for modulation of immune response
WO2008124086A2 (en) 2007-04-05 2008-10-16 President And Fellows Of Harvard College Chimeric activators: quantitatively designed protein therapeutics and uses thereof
WO2009003145A1 (en) 2007-06-26 2008-12-31 University Of Miami Antibody-endostatin fusion protein and its variants
GB0805159D0 (en) 2008-03-19 2008-04-23 Sancho Madrid David Immune modulation via C-type lectin
CN101868246A (zh) 2007-09-21 2010-10-20 加利福尼亚大学董事会 被导靶的干扰素显示强的细胞凋亡和抗肿瘤活性
WO2010030671A1 (en) 2008-09-09 2010-03-18 University Of Medicine And Dentistry Of New Jersey Type i interferon antagonists
US8334101B2 (en) 2008-09-26 2012-12-18 University Of Massachusetts Intracellular DNA receptor
WO2010066740A1 (en) 2008-12-08 2010-06-17 Complix Nv Single-chain antiparallel coiled coil proteins
CA2755983A1 (en) 2009-03-23 2010-09-30 The Walter And Eliza Hall Institute Of Medical Research Compounds and methods for modulating an immune response
JP5764127B2 (ja) 2009-08-17 2015-08-12 ロシュ グリクアート アーゲー 標的化イムノコンジュゲート
JP2013504539A (ja) 2009-09-10 2013-02-07 サイトス バイオテクノロジー アーゲー 糖尿病治療におけるインターロイキン1βムテイン・コンジュゲートの使用
RU2577299C2 (ru) 2011-07-04 2016-03-10 Олег Ильич Эпштейн Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
US9534056B2 (en) 2011-06-06 2017-01-03 Immungene Inc Engineered TAA antibody-TNFSF member ligand fusion molecules
WO2013053008A2 (en) 2011-10-14 2013-04-18 The Walter And Eliza Hall Institute Of Medical Research Molecules which bind clec9a
EP3559049B1 (en) 2011-10-28 2025-06-11 Teva Pharmaceuticals Australia Pty Ltd Polypeptide constructs and uses thereof
ES2694180T3 (es) 2012-01-20 2018-12-18 Vib Vzw Citocinas de haz alfa-helicoidal mutantes dirigidas
PT2822575T (pt) 2012-03-03 2020-07-02 Immungene Inc Moléculas de fusão anticorpos-mutante de interferão modificadas
EP2872158A1 (en) 2012-05-01 2015-05-20 The University of Sydney Vaccine and uses thereof
CA2878626A1 (en) 2012-08-09 2014-02-13 Roche Glycart Ag Asgpr antibodies and uses thereof
KR20150131208A (ko) 2013-03-13 2015-11-24 이미지냅 인코포레이티드 Cd8에의 항원 결합 구조체들
EP2992101B1 (en) 2013-04-29 2018-10-10 Agrosavfe N.V. Agrochemical compositions comprising antibodies binding to sphingolipids
KR102322510B1 (ko) 2013-07-18 2021-11-08 브이아이비 브이지더블유 수용체 결합친화성이 현격히 감소된 사이토카인을 수반하는 푸소카인
JP6595988B2 (ja) 2013-07-19 2019-10-23 ヴィブ ブイゼットダブリュー ターゲットされる修飾tnfファミリーメンバー
BR112016001128A2 (pt) 2013-07-19 2018-01-23 Vib Vzw membros da família il-1 modificados direcionados
SG10202010429YA (en) 2013-07-19 2020-11-27 Vib Vzw Targeting of cytokine antagonists
PT3444271T (pt) 2013-08-08 2022-01-05 Inst Nat Sante Rech Med Modulocinas baseadas em il-15 e no domínio sushi de il-15ralfa
UA119352C2 (uk) 2014-05-01 2019-06-10 Тева Фармасьютикалз Острейліа Пті Лтд Комбінація леналідоміду або помалідоміду і конструкції анти-cd38 антитіло-атенуйований інтерферон альфа-2b та спосіб лікування суб'єкта, який має cd38-експресуючу пухлину
WO2016187459A1 (en) 2015-05-20 2016-11-24 The Regents Of The University Of California Method for generating human dendritic cells for immunotherapy
WO2017077382A1 (en) 2015-11-06 2017-05-11 Orionis Biosciences Nv Bi-functional chimeric proteins and uses thereof
CN116769054A (zh) * 2016-02-05 2023-09-19 奥里尼斯生物科学私人有限公司 双特异性信号传导剂及其用途
EP3426278B1 (en) 2016-03-07 2024-01-03 Vib Vzw Cd20 binding single domain antibodies
WO2017165464A1 (en) 2016-03-21 2017-09-28 Elstar Therapeutics, Inc. Multispecific and multifunctional molecules and uses thereof
EP3455245A2 (en) 2016-05-13 2019-03-20 Orionis Biosciences NV Therapeutic targeting of non-cellular structures
WO2017194783A1 (en) 2016-05-13 2017-11-16 Orionis Biosciences Nv Targeted mutant interferon-beta and uses thereof
WO2018077893A1 (en) 2016-10-24 2018-05-03 Orionis Biosciences Nv Targeted mutant interferon-gamma and uses thereof
KR102642385B1 (ko) 2017-02-06 2024-03-04 오리오니스 바이오사이언시스 엔브이 표적화된 키메라 단백질 및 이의 용도
CN110573172A (zh) 2017-02-06 2019-12-13 奥里尼斯生物科学有限公司 靶向的工程化干扰素及其用途
WO2018146074A1 (en) 2017-02-07 2018-08-16 Vib Vzw Immune-cell targeted bispecific chimeric proteins and uses thereof
AU2018313810B2 (en) 2017-08-09 2025-05-15 Orionis Biosciences BV Clec9A binding agents and use thereof
EP3664829A4 (en) 2017-08-09 2021-05-05 Orionis Biosciences, Inc. LIAISON OFFICERS AT PD-1 AND PD-L1
CN111511763B (zh) 2017-08-09 2024-05-31 奥里尼斯生物科学有限公司 Cd8结合剂
EP3743448A4 (en) 2018-01-26 2021-11-03 Orionis Biosciences, Inc. XCR1 BINDING AGENTS AND USES THEREOF
KR102877915B1 (ko) 2018-02-05 2025-10-29 오리오니스 바이오사이언시즈 인코포레이티드 섬유아세포 결합제 및 이의 용도
KR20210005872A (ko) * 2018-03-28 2021-01-15 오리오니스 바이오사이언시즈 인코포레이티드 이작용성 단백질 및 이의 작제물
WO2020033646A1 (en) 2018-08-08 2020-02-13 Orionis Biosciences, Inc. SIRP1α TARGETED CHIMERIC PROTEINS AND USES THEREOF
US12351614B2 (en) * 2019-03-28 2025-07-08 Orionis Biosciences, Inc. CLEC9A-based chimeric protein complexes

Similar Documents

Publication Publication Date Title
JP2022530742A5 (https=)
JP2023504914A5 (https=)
JP2021007390A5 (https=)
US10214579B2 (en) Fc fusion proteins comprising novel linkers or arrangements
CA2892623C (en) Ch3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof
JP5753903B2 (ja) 活性化可能な二重特異性抗体
CN107922486B (zh) 异源二聚体多特异性抗体形式
JP2024153643A5 (https=)
JP2023123649A5 (https=)
JP2023518518A5 (https=)
JP2022512043A5 (https=)
JP2016525551A5 (https=)
JP2013534812A5 (https=)
DK2921503T3 (en) Human antibody to human epidermal growth factor receptor and coding gene and its use
JP2021505156A5 (https=)
JP2020530770A5 (https=)
JP2024509904A5 (https=)
Blanco-Toribio et al. Generation and characterization of monospecific and bispecific hexavalent trimerbodies
CN113840833B (zh) 基于clec9a的嵌合蛋白复合物
JP2023552462A5 (https=)
JP2022548364A5 (https=)
JP2024534795A (ja) 二重特異性抗体およびその使用
CN107226866A (zh) 一种抗cd24人源化抗体融合蛋白
JP2019518713A5 (https=)
KR20250028265A (ko) 항체 및 이의 용도